Intended for healthcare professionals


Offer daily aspirin to cut risk of colorectal cancer in people with Lynch syndrome, says NICE

BMJ 2019; 366 doi: (Published 02 August 2019) Cite this as: BMJ 2019;366:l5010
  1. Pat Lok,
  2. Stijntje Dijk
  1. The BMJ

People with the inherited disease Lynch syndrome should be offered daily aspirin to reduce their risk of colorectal cancer, the National Institute for Health and Care Excellence (NICE) has said in draft guidance.1

People with Lynch syndrome have a 50-80% increased risk of colorectal cancer,2 the second leading cause of cancer deaths in the UK.

This is the first time that NICE has included advice about aspirin for reducing the risk of colorectal cancer among people with Lynch syndrome, although …

View Full Text

Log in

Log in through your institution


* For online subscription